For example, RASSF1A is silenced by promoter hypermethylation in 100% of SCLCs and in 63% of NSCLCs cell lines and in 50-100% SCLC and 21-58% NSCLC primary tumors [25-28]. The gene discussed is RASSF1; the disease is small cell lung carcinoma.